Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0104 | 0.2511 | 0.2511 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0358 | 1 | 1 |
Trypanosoma cruzi | aldo-keto reductase | 0.0358 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase | 0.0358 | 1 | 1 |
Echinococcus granulosus | aldehyde reductase | 0.0254 | 0.6946 | 0.6946 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0358 | 1 | 1 |
Onchocerca volvulus | 0.0358 | 1 | 1 | |
Trypanosoma brucei | aldo-keto reductase, putative | 0.0358 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0104 | 0.2511 | 0.2511 |
Onchocerca volvulus | 0.0358 | 1 | 1 | |
Trypanosoma brucei | aldo/keto reductase, putative | 0.0104 | 0.2511 | 0.2511 |
Giardia lamblia | Aldose reductase | 0.0358 | 1 | 1 |
Onchocerca volvulus | 0.0358 | 1 | 1 | |
Trichomonas vaginalis | aldo/keto reductase, putative | 0.0358 | 1 | 1 |
Loa Loa (eye worm) | oxidoreductase | 0.0358 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase | 0.0358 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0358 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0358 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase | 0.0358 | 1 | 1 |
Toxoplasma gondii | aldose reductase, putative | 0.0358 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0358 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0104 | 0.2511 | 0.2511 |
Trichomonas vaginalis | aldo/keto reductase, putative | 0.0358 | 1 | 1 |
Leishmania major | aldo-keto reductase-like protein | 0.0358 | 1 | 1 |
Trypanosoma cruzi | aldo/keto reductase, putative | 0.0358 | 1 | 1 |
Schistosoma mansoni | pol-related | 0.0358 | 1 | 1 |
Echinococcus multilocularis | voltage gated potassium channel subunit | 0.0104 | 0.2511 | 0.2511 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0358 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0358 | 1 | 1 |
Plasmodium falciparum | aldehyde reductase, putative | 0.0104 | 0.2511 | 1 |
Toxoplasma gondii | oxidoreductase, aldo/keto reductase family protein | 0.0104 | 0.2511 | 0.2511 |
Giardia lamblia | Aldose reductase | 0.0358 | 1 | 1 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0254 | 0.6946 | 0.5922 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0358 | 1 | 1 |
Leishmania major | aldo/keto reductase, putative,aldo/keto reductase family-like protein | 0.0104 | 0.2511 | 0.2511 |
Loa Loa (eye worm) | oxidoreductase | 0.0358 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0358 | 1 | 1 |
Onchocerca volvulus | 0.0358 | 1 | 1 | |
Brugia malayi | oxidoreductase, aldo/keto reductase family protein | 0.0358 | 1 | 1 |
Trypanosoma brucei | prostaglandin f synthase | 0.0358 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0358 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0358 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0358 | 1 | 1 |
Onchocerca volvulus | 0.0358 | 1 | 1 | |
Loa Loa (eye worm) | oxidoreductase | 0.0358 | 1 | 1 |
Loa Loa (eye worm) | oxidoreductase | 0.0358 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0358 | 1 | 1 |
Leishmania major | aldehyde reductase, putative,oxidoreductase, putative | 0.0358 | 1 | 1 |
Plasmodium vivax | aldehyde reductase, putative | 0.0104 | 0.2511 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0358 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase | 0.0358 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0358 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0358 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0358 | 1 | 1 |
Mycobacterium ulcerans | oxidoreductase | 0.0358 | 1 | 1 |
Toxoplasma gondii | aldo/keto reductase family oxidoreductase | 0.0104 | 0.2511 | 0.2511 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0358 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0358 | 1 | 1 |
Trichomonas vaginalis | dihydrodiol dehydrogenase, putative | 0.0358 | 1 | 1 |
Brugia malayi | oxidoreductase, aldo/keto reductase family protein | 0.0358 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0358 | 1 | 1 |
Echinococcus granulosus | voltage gated potassium channel subunit | 0.0104 | 0.2511 | 0.2511 |
Entamoeba histolytica | aldose reductase, putative | 0.0358 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase family 1, member B4 | 0.0104 | 0.2511 | 0.2511 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0358 | 1 | 1 |
Brugia malayi | glutamate-cysteine ligase modifier subunit | 0.0104 | 0.2511 | 0.2511 |
Onchocerca volvulus | 0.0358 | 1 | 1 | |
Trichomonas vaginalis | dihydrodiol dehydrogenase, putative | 0.0358 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0358 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0358 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0358 | 1 | 1 |
Trichomonas vaginalis | aldo/keto reductase, putative | 0.0358 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0358 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase | 0.0358 | 1 | 1 |
Toxoplasma gondii | aldo-keto reductase | 0.0104 | 0.2511 | 0.2511 |
Plasmodium vivax | oxidoreductase, aldo/keto reductase domain containing protein | 0.0104 | 0.2511 | 1 |
Entamoeba histolytica | alcohol dehydrogenase, putative | 0.0104 | 0.2511 | 0.2511 |
Leishmania major | prostaglandin f2-alpha synthase/D-arabinose dehydrogenase | 0.0358 | 1 | 1 |
Leishmania major | prostaglandin f synthase, putative | 0.0358 | 1 | 1 |
Entamoeba histolytica | aldose reductase, putative | 0.0358 | 1 | 1 |
Brugia malayi | oxidoreductase, aldo/keto reductase family protein | 0.0358 | 1 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0104 | 0.2511 | 0.2511 |
Mycobacterium tuberculosis | Conserved protein | 0.0104 | 0.2511 | 0.2511 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0358 | 1 | 1 |
Schistosoma mansoni | aldo-keto reductase | 0.0358 | 1 | 1 |
Loa Loa (eye worm) | glutamate-cysteine ligase modifier subunit | 0.0104 | 0.2511 | 0.2511 |
Mycobacterium leprae | PROBABLE OXIDOREDUCTASE | 0.0358 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0018 | 0 | 0.5 |
Echinococcus multilocularis | aldo keto reductase | 0.0358 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0358 | 1 | 1 |
Entamoeba histolytica | aldose reductase, putative | 0.0358 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0358 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0358 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0358 | 1 | 1 |
Trichomonas vaginalis | dihydrodiol dehydrogenase, putative | 0.0358 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0358 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase | 0.0358 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0358 | 1 | 1 |
Echinococcus multilocularis | aldehyde reductase | 0.0254 | 0.6946 | 0.6946 |
Schistosoma mansoni | aldo-keto reductase | 0.0358 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0358 | 1 | 1 |
Loa Loa (eye worm) | oxidoreductase | 0.0358 | 1 | 1 |
Echinococcus granulosus | hypothetical protein | 0.0358 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0104 | 0.2511 | 0.2511 |
Trypanosoma cruzi | aldo/keto reductase, putative | 0.0104 | 0.2511 | 0.2511 |
Schistosoma mansoni | potassium channel beta | 0.0104 | 0.2511 | 0.2511 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0018 | 0 | 0.5 |
Brugia malayi | NADH-dependent xylose reductase | 0.0104 | 0.2511 | 0.2511 |
Entamoeba histolytica | alcohol dehydrogenase, putative | 0.0104 | 0.2511 | 0.2511 |
Trichomonas vaginalis | alcohol dehydrogenase, putative | 0.0104 | 0.2511 | 0.2511 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0358 | 1 | 1 |
Plasmodium falciparum | aldo-keto reductase, putative | 0.0104 | 0.2511 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Distribution of radioactivity (ADMET) | = 0.01 dose g-1 | Distribution of radioactivity was determined in blood at 24 hr after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 0.01 dose g-1 | Distribution of radioactivity was determined in plasma at 24 hr after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 0.02 dose g-1 | Distribution of radioactivity was determined in blood at 3h after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 0.03 dose g-1 | Distribution of radioactivity was determined in kidney at 3h after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 0.03 dose g-1 | Distribution of radioactivity was determined in plasma at 3h after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 0.05 dose g-1 | Distribution of radioactivity was determined in kidney at 24 hr after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 0.06 dose g-1 | Distribution of radioactivity was determined in heart at 24 after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 0.07 dose g-1 | Distribution of radioactivity was determined in kidney at 30 min after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 0.1 dose g-1 | Distribution of radioactivity was determined in blood at 24 hr after intravenous administration of 1,3-Disubstituted Triacylglycerols in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 0.1 dose g-1 | Distribution of radioactivity was determined in blood at 48 hr after intravenous administration of 1,3-Disubstituted Triacylglycerols in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 0.2 dose g-1 | Distribution of radioactivity was determined in lung at 3h after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 0.25 dose g-1 | Distribution of radioactivity was determined in heart at 3h after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 0.26 dose g-1 | Distribution of radioactivity was determined in blood at 30 min after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 0.3 dose g-1 | Distribution of radioactivity was determined in blood at 3h after intravenous administration of 1,3-Disubstituted Triacylglycerols in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 0.34 dose g-1 | Distribution of radioactivity was determined in lung at 30 min after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 0.42 dose g-1 | Distribution of radioactivity was determined in plasma at 30 min after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 0.62 dose g-1 | Distribution of radioactivity was determined in lung at 24 hr after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 0.84 dose g-1 | Distribution of radioactivity was determined in heart at 30 min after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 2.6 dose g-1 | Distribution of radioactivity was determined in blood at 30 min after intravenous administration of 1,3-Disubstituted Triacylglycerols in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 2.88 dose g-1 | Distribution of radioactivity was determined in thyroid at 30 min after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 5.08 dose g-1 | Distribution of radioactivity was determined in thyroid at 3h after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 9 dose g-1 | Distribution of radioactivity was determined in liver at 3h after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 9.67 dose g-1 | Distribution of radioactivity was determined in liver at 30 min after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 9.8 dose g-1 | Distribution of radioactivity was determined in spleen at 48 hr after intravenous administration of 1,3-Disubstituted Triacylglycerols in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 10.25 dose g-1 | Distribution of radioactivity was determined in liver at 24 hr after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 11.3 dose g-1 | Distribution of radioactivity was determined in spleen at 3h after intravenous administration of 1,3-Disubstituted Triacylglycerols in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 12.5 dose g-1 | Distribution of radioactivity was determined in spleen at 24 hr after intravenous administration of 1,3-Disubstituted Triacylglycerols in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 14.4 dose g-1 | Distribution of radioactivity was determined in spleen at 30 min after intravenous administration of 1,3-Disubstituted Triacylglycerols in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 17.31 dose g-1 | Distribution of radioactivity was determined in thyroid at 24 hr after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 17.66 dose g-1 | Distribution of radioactivity was determined in spleen at 3h after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 21.7 dose g-1 | Distribution of radioactivity was determined in spleen at 24 hr after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 24.82 dose g-1 | Distribution of radioactivity was determined in spleen at 30 min after intravenous administration of [125I]-labeled 2-oleoglycerol 1,3-Bis-[omega-(3-amino-2,4,6-triiodophenyl)alkanoates] in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 71.6 dose g-1 | Distribution of radioactivity was determined in liver at 48 hr after intravenous administration of 1,3-Disubstituted Triacylglycerols in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 77 dose g-1 | Distribution of radioactivity was determined in liver at 24 hr after intravenous administration of 1,3-Disubstituted Triacylglycerols in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 78 dose g-1 | Distribution of radioactivity was determined in liver at 30 min after intravenous administration of 1,3-Disubstituted Triacylglycerols in rats | ChEMBL. | 7861412 |
Distribution of radioactivity (ADMET) | = 80 dose g-1 | Distribution of radioactivity was determined in liver at 3h after intravenous administration of 1,3-Disubstituted Triacylglycerols in rats | ChEMBL. | 7861412 |
Lipid-soluble radioactivity (ADMET) | = 0 | Analysis of lipid-soluble radioactivity in plasma 24 hour after iv administration of [125I]-labeled 2-Oleoyl 1,3-disubstituted Triacylglycerols expressed as %parent compound (by TLC with authentic [125I]-labeled standard) from rat | ChEMBL. | 7861412 |
Lipid-soluble radioactivity (ADMET) | = 26.5 | Analysis of lipid-soluble radioactivity in plasma 0.5 hour after iv administration of [125I]-labeled 2-Oleoyl 1,3-disubstituted Triacylglycerols expressed as %parent compound (by TLC with authentic [125I]-labeled standard) from rat | ChEMBL. | 7861412 |
Lipid-soluble radioactivity (ADMET) | = 64.7 | Analysis of lipid-soluble radioactivity in liver 24 hour after iv administration of [125I]-labeled 2-Oleoyl 1,3-disubstituted Triacylglycerols expressed as %parent compound (by TLC with authentic [125I]-labeled standard) from rat | ChEMBL. | 7861412 |
Lipid-soluble radioactivity (ADMET) | = 78.6 | Analysis of lipid-soluble radioactivity in liver 0.5 hour after iv administration of [125I]-labeled 2-Oleoyl 1,3-disubstituted Triacylglycerols expressed as %parent compound (by TLC with authentic [125I]-labeled standard) from rat | ChEMBL. | 7861412 |
Lipid-soluble radioactivity (ADMET) | = 83 | Analysis of lipid-soluble radioactivity in plasma 24 hour after iv administration of [125I]-labeled 2-Oleoyl 1,3-disubstituted Triacylglycerols and represented as % CHCl3/CH3OH from rat | ChEMBL. | 7861412 |
Lipid-soluble radioactivity (ADMET) | = 88.2 | Analysis of lipid-soluble radioactivity in plasma 0.5 hour after iv administration of [125I]-labeled 2-Oleoyl 1,3-disubstituted Triacylglycerols and represented as % CHCl3/CH3OH from rat | ChEMBL. | 7861412 |
Lipid-soluble radioactivity (ADMET) | = 93.7000000000001 | Analysis of lipid-soluble radioactivity in liver 24 hour after iv administration of [125I]-labeled 2-Oleoyl 1,3-disubstituted Triacylglycerols and represented as % CHCl3/CH3OH from rat | ChEMBL. | 7861412 |
Lipid-soluble radioactivity (ADMET) | = 97.5 | Analysis of lipid-soluble radioactivity in liver 0.5 hour after iv administration of [125I]-labeled 2-Oleoyl 1,3-disubstituted Triacylglycerols and represented as % CHCl3/CH3OH from rat | ChEMBL. | 7861412 |
Radioactivity (ADMET) | = 1.5 % | Polyacramide Gel Electrophoresis(PAGE) to determined the concentration of below albumin(BA) in rats after iv administration of [125I]-labeled 2-Oleolyl 1,3-disubstituted triglycerols was reported | ChEMBL. | 7861412 |
Radioactivity (ADMET) | = 2.5 % | Polyacramide Gel Electrophoresis(PAGE) to determined the concentration of high density lipoprotein(HDL) in rats after iv administration of [125I]-labeled 2-Oleolyl 1,3-disubstituted triglycerols was reported | ChEMBL. | 7861412 |
Radioactivity (ADMET) | = 4.9 % | Polyacramide Gel Electrophoresis(PAGE) to determined the concentration of albumin(ALB) in rats after iv administration of [125I]-labeled 2-Oleolyl 1,3-disubstituted triglycerols was reported | ChEMBL. | 7861412 |
Radioactivity (ADMET) | = 7.4 % | Polyacramide Gel Electrophoresis(PAGE) to determined the concentration of low density lipoprotein(LDL) in rats after iv administration of [125I]-labeled 2-Oleolyl 1,3-disubstituted triglycerols was reported | ChEMBL. | 7861412 |
Radioactivity (ADMET) | = 83.5000000000002 % | Polyacramide Gel Electrophoresis(PAGE) to determined the concentration of stacking gel(SG) in rats after iv administration of [125I]-labeled 2-Oleolyl 1,3-disubstituted triglycerols was reported | ChEMBL. | 7861412 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.